ACE2 and Hepatic fibrosis: Modulation of other RAAS components (inhibition of ACE/Ang II/AT1R and stimulation of ACE2/Ang 1–7/Mas signaling pathways) was also shown to reduce hepatic fibrosis in a rodent model of hepatic fibrosis.